Gyre Therapeutics
GYRE
GYRE
79 hedge funds and large institutions have $81.8M invested in Gyre Therapeutics in 2020 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 22 increasing their positions, 16 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
38% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 16
0.19% less ownership
Funds ownership: 8.61% → 8.42% (-0.19%)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
79
Holding in Top 10
2
Calls
$875K
Puts
$544K
Top Buyers
| 1 | +$4.73M | |
| 2 | +$2.2M | |
| 3 | +$2.1M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.59M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
+$1.28M |
Top Sellers
| 1 | -$2.77M | |
| 2 | -$1.43M | |
| 3 | -$1.22M | |
| 4 |
PM
Prosight Management
Dallas,
Texas
|
-$792K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$603K |